HIV Malignancy Specimens for Research at No Charge
Congratulations to National Cancer Institute (NCI) Center for Global Health (CGH) Director, Satish Gopal, recipient of American Society of Clinical Oncology (ASCO) 2024 Humanitarian Award, recognizing his outstanding leadership in …
City of Hope’s, in person and virtual, Global Oncology Symposium on Oncogenic Viruses will take place Fri, Oct 27, 8 a.m.-3:30 p.m. PDT. The symposium promises to cover a comprehensive …
Read “Tackling cancer globally requires research commitments in LMICs”, the latest Worldview Editorial in Nature written by Dr. Satish Gopal, Director of the National Cancer Institute’s Center for Global Health. …
From Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 NCI encourages applications for pragmatic clinical trials to generate evidence that directly informs decision-making among patients, providers, …
From RFA-CA-24-005 This Notice of Funding Opportunity (NOFO) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects …
Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI’s Center for Global Health is now offering full-time, one-year …
Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI’s Center for Global Health is now offering full-time, one-year …
The purpose of this Notice is to encourage current funded NCI extramural investigators to apply for administrative supplements to support mentored cancer research career development of early-stage low- and middle-income …
NOT-CA-22-031 Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) The purpose of this announcement …
RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement …